EZZ Life Science hosts gastrointestinal health conference in Sydney
By George Tchetvertakov There is a palatable global trend towards greater health consciousness and it’s accelerating, Australian life science company EZZ Life Science (ASX: EZZ) told attendees at its gastrointestinal health conference last week. With the COVID-19 pandemic now ebbing away, albeit gradually, it’s not just Australians that have learned a valuable lesson in health. …
Read more “EZZ Life Science hosts gastrointestinal health conference in Sydney”
Transformative: EZZ achieves milestone biotech and life sciences listing on ASX
EZZ has achieved a significant milestone after being reclassified on the ASX as the genome-specialist looks to broaden its market share in the biotech and life sciences sector. Aussie-listed genomic-tech firm, EZZ Life Science Holdings (ASX:EZZ) has had its listing changed on the bourse from retail to a pharmaceutical, biotechnology and life sciences company. The …
Read more “Transformative: EZZ achieves milestone biotech and life sciences listing on ASX”
The EZZ Gastrointestinal Health Conference was held in Sydney
Speakers including Luis Vitetta, Clinical Prof. with @Sydney_Uni, Gemma Acton, Network Finance Manager @7NewsSydney and Glenn Cross, EZZ Life Science Chairman.
